Answers are grounded in this paper and cite their sources.
Retrospective study evaluates PTEN and ERG expression in prostate carcinoma, indicating PTEN's prognostic value.
Background: Prostate carcinoma is the second most common cancer in men worldwide and a leading cause of cancer-related mortality, particularly in low- and middle-income countries. Prognostic assessment relies largely on International Society of Urological Pathology grading, which has recognized limitations. Molecular alterations, including phosphatase and tensin homolog (PTEN) loss and ETS-related gene (ERG) rearrangements, contribute to prostate carcinogenesis. This study aimed to evaluate immunohistochemical expression of PTEN and ERG across low-, intermediate-, and high-grade prostate carcinomas diagnosed at UNIOSUN Teaching Hospital, Osogbo, Nigeria.Materials and Methods: This retrospective observational study included 70 histologically confirmed prostate carcinoma cases diagnosed between January 2017 and December 2021. Formalin-fixed, paraffin-embedded tissue blocks were stained with monoclonal antibodies against PTEN and ERG. PTEN positivity was defined as >10% combined nuclear and cytoplasmic tumor staining, and ERG positivity was defined as strong nuclear staining in >20% of tumor cells. Associations between biomarker expression and tumor grade were assessed using the chi-square test (p<0.05).Results: Prostate carcinoma accounted for 13.3% (102 of 768) of all male solid tumors during the study period. The mean age of analyzed cases was 72.9±9.1 years (range, 47–91 years). PTEN loss was observed in 25.7% (18 of 70) of cases and was most frequent in high-grade tumors (51.6%, 16 of 31; p=0.001). ERG expression was not detected in any case, although internal and external controls stained appropriately.Conclusion: PTEN loss was significantly associated with high-grade prostate carcinoma, supporting its potential role as an adjunct prognostic biomarker. The absence of ERG expression may reflect populationspecific molecular patterns or archival tissue limitations and warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Towoju et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: